Immunic, Inc. is trading at $13.25 (8.1% up) in after-hours trading as the stock rebounds from recent weakness despite a lack of fresh company-specific news.

  • The move extends a regular-session close of $12.26, following a period of sharp declines for the stock.
  • No new earnings reports, regulatory updates, or major analyst actions have been identified to account for the late-day surge.
  • The price action appears driven by continued volatility and technical positioning rather than fundamental developments, occurring against a generally weaker broader market backdrop.